MedPath

High-Intensity Functional Training for Polycystic Ovary Syndrome

Not Applicable
Terminated
Conditions
Polycystic Ovary Syndrome
Metabolic and Endocrine - Other endocrine disorders
Reproductive Health and Childbirth - Other reproductive health and childbirth disorders
Registration Number
ACTRN12622000639729
Lead Sponsor
Western Sydney University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
Female
Target Recruitment
4
Inclusion Criteria

To participate in this study, participants must:
•be between the ages of 18-40 years;
•have a diagnosis of polycystic ovary syndrome (PCOS) as per Rotterdam 2003 criteria;
•be physically inactive (undertaking < 150 minutes of exercise per week or exercising < 3 days per week);
•have overweight or obesity (BMI between 25 to 40 kg/m2);
•able to attend three training sessions per week at F45® Bulli or Corrimal for 12 weeks;
•ability to read and communicate in the English language.

Exclusion Criteria

Participants will be excluded from this study if they:
•have a condition for which high-intensity exercise is contraindicated (such as uncontrolled hypertension, stroke, or other cardiovascular diseases);
•are pregnant or were pregnant in the last 6 months;
•have type 2 diabetes;
•consume more than 20g/day of alcohol;
•have a rapidly progressive disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiorespiratory fitness assessed via graded exercise test and gas analysis.[ Assessed at baseline and at 13 weeks post-intervention commencement. ];Muscular strength assessed via one repetition maximum of chest press and leg press exercises.[ Assessed at baseline and at 13 weeks post-intervention commencement. ];Muscle endurance via maximal repetitions to failure at 70% 1RM for the bench press and back squat exercises.[ Assessed at baseline and at 13 weeks post-intervention commencement. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath